Get hold of us
Send us a message
Oncolytic virotherapy represents an exciting new area of cancer treatment which exploits a virus’s ability to selectively replicate and kill tumor tissue while stimulating a patient-specific immune response against cancer. Interest in the field is at an all-time high following several significant deals. However, questions still remain around delivery, product and clinical development, pre-clinical modelling, scale-up, manufacturing and suitable commercial models. CHI’s Second Annual Oncolytic Virus Immunotherapy conference brings together the leading industry and academic leaders to discuss the critical steps driving oncolytic virotherapy forward.
VENUE: Sheraton Boston | Boston, MA
The International Cancer Immunotherapy Conference covers all areas of inquiry in cancer immunology and immunotherapy.
VENUE: Rheingoldhalle Congress Center, Mainz / Frankfurt, Germany
32nd Annual meeting of The Society for Immunotherapy of Cancer
VENUE: Gaylord National Resort & Convention Center, 201 Waterfront St., National Harbor, MD. 20745